Viewing data from:

GRIFULVIN V

ANDA

GRISEOFULVIN, MICROCRYSTALLINE | A062279 | VALEANT PHARMACEUTICALS LUXEMBOURG SARL

3 strengths0 unique patents0 unique exclusivities

Products (3)

Sort:

#001 — 125MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Approved Prior to Jan 1, 1982

No patent or exclusivity listings for this strength.

#002 — 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Approved Prior to Jan 1, 1982

#003 — 500MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Approved Prior to Jan 1, 1982